Cancer

Using CRISPR technology, Whitehead Institute Member Jonathan Weissman is tracking the lineage of individual cancer cells as they proliferate and metastasize in real time. 

December 21, 2020

Researchers in the lab of Whitehead Institute Founding Member Robert Weinberg have determined how mesenchymal cancer cells may resist treatment, work that may allow them to make once-resistant tumors respond to certain cancer therapies.

July 02, 2020

Whitehead Institute’s core facilities set it apart. The cores, staffed by experts and providing state-of-the-art instrumentation and tools, allow our scientists to pursue more ambitious investigations.